J. Retsema

发表

Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo.

W. Milisen, J. Retsema, A. Girard, 1990, The Journal of antimicrobial chemotherapy.

Rationale for the Use of Azithromycin as Mycobacterium avium Chemoprophylaxis

G. Foulds, M. Dunne, J. Retsema, 1997 .

In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens.

B. Yang, M. Letavic, N. A. Evans, 2004, The Journal of antibiotics.

In vitro Microbiological Characterization of a Novel Azalide, Two Triamilides and an Azalide Ketal Against Bovine and Porcine Respiratory Pathogens.

B. Yang, Letavic Michael Anthony, N. A. Evans, 2004 .

In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.

M. Lemay, S. Hecker, J. Retsema, 1998, The Journal of antibiotics.

Inactivation of Escherichia coli ribosomes by 1-fluoro-2,4-dinitrobenzene.

T. Conway, J. Retsema, 1971, Journal of molecular biology.

Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection

M. Ammirati, D. Danley, L. James, 1996, Antimicrobial Agents and Chemotherapy.

Correlation Between the Binding of β-Lactam Antibiotics to Staphylococcus aureus and Their Physical-Chemical Properties

J. Retsema, V. Ray, 1972, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

A. R. English, T. Gootz, J. Retsema, 1987, Antimicrobial Agents and Chemotherapy.

Macrolides: structures and microbial targets.

W. Fu, J. Retsema, Wenchi Fu, 2001, International journal of antimicrobial agents.

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

J. Retsema, A. Girard, G. Bright, 1987, Antimicrobial Agents and Chemotherapy.

Synthesis and beta-lactamase inhibitory activity of thiazolyl penam sulfones.

J. Barrett, J. Retsema, Y. L. Chen, 1988, The Journal of antibiotics.

CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization

A. R. English, W. Barth, J. Retsema, 1978, Antimicrobial Agents and Chemotherapy.

Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones; a new class of beta-lactamase inhibitors.

L. Kiessling, K. Guarino, J. Retsema, 1987, The Journal of antibiotics.

In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents

T. Gootz, S. Sokolowski, J. Retsema, 1989, Antimicrobial Agents and Chemotherapy.

Cephalosporins to carbapenems: 1-oxygenated carbapenems and carbapenams.

J. Retsema, R. L. Rosati, P. Morrissey, 1990, Journal of medicinal chemistry.

Pirbenicillin: Pharmacokinetic Parameters in Mice

A. R. English, J. Retsema, D. Girard, 1976, Antimicrobial Agents and Chemotherapy.

Preferential concentration of azithromycin in an infected mouse thigh model.

W. Milisen, J. Retsema, A. Girard, 1993, The Journal of antimicrobial chemotherapy.

CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides

A. R. English, J. Retsema, A. Girard, 1980, Antimicrobial Agents and Chemotherapy.

Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenes

A. Kamath, W. Yuan, F. Dib-Hajj, 1996, Molecular microbiology.

Laboratory Evaluation of 3-(5-Tetrazolyl)Penam, a New Semisynthetic Beta-Lactam Antibacterial Agent with Extended Broad-Spectrum Activity

A. R. English, J. Retsema, J. Lynch, 1976, Antimicrobial Agents and Chemotherapy.

Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450

D. Amacher, S. Schomaker, J. Retsema, 1991, Antimicrobial Agents and Chemotherapy.

Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.

J. Retsema, A. Girard, D. Girard, 1990, The Journal of antimicrobial chemotherapy.

Carbenicillin Indanyl Sodium, an Orally Active Derivative of Carbenicillin

A. R. English, J. Retsema, V. Ray, 1972, Antimicrobial Agents and Chemotherapy.

Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives

A. R. English, A. Nagel, J. Retsema, 1984, Antimicrobial Agents and Chemotherapy.

Efficacy of azithromycin for treating Babesia microti infection in the hamster model.

L. Weiss, H. Tanowitz, H. Oz, 1993, The Journal of infectious diseases.

Properties of ribosomal binding sites for phenylalanyl-transfer ribonucleic acid.

N. Seeds, J. Retsema, T. Conway, 1967, Journal of molecular biology.

(6R,8S)-(2-benzimidazolyl)hydroxymethylpenicillanic acids as potent antibacterial agents and beta-lactamase inhibitors.

K. Guarino, J. Barrett, J. Retsema, 1991, The Journal of antibiotics.

Side chain modifications in lankacidin group antibiotics

A. R. English, J. McFarland, J. Retsema, 1984, Antimicrobial Agents and Chemotherapy.

Susceptibility and resistance emergence studies with macrolides.

J. Retsema, 1999, International journal of antimicrobial agents.

Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues.

A. C. Swindell, W. Milisen, J. Retsema, 1996, The Journal of antimicrobial chemotherapy.

Orally Active Derivative of Carbenicillin

A. R. English, J. Retsema, V. Ray, 2022 .

Reversible dissociation of Escherichia coli ribosomes by N-ethylmaleimide.

T. Conway, J. Retsema, 1969, Biochimica et biophysica acta.

In vitro microbiological characterization of novel cyclic homopentapeptides, CP-101,680 and CP-163,234, for animal health use.

J. Dirlam, R. Schnur, J. Retsema, 1999, The Journal of antibiotics.

In vitro Microbiological Characterization of Novel Macrolide CP‐163,505 for Animal Health Specific Use.

M. Lemay, S. Hecker, J. Retsema, 1998 .

Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.

A. R. English, J. Retsema, D. Girard, 1986, Reviews of infectious diseases.

Effects of environmental factors on the in vitro potency of azithromycin

J. Retsema, A. Girard, L. Brennan, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

A. R. English, J. Retsema, A. Girard, 1986, Reviews of infectious diseases.

Laboratory Studies with a New Broad-Spectrum Penicillin, Pirbenicillin

A. R. English, J. Retsema, J. Lynch, 1976, Antimicrobial Agents and Chemotherapy.

Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency

A. R. English, J. Retsema, A. Girard, 1984, Antimicrobial Agents and Chemotherapy.